Latest news
SciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock TitanStock Titan · Wed, 05 Aug 2026 13:00:51 GMTSciSparc: Subsidiary NeuroThera Labs Launches Phase IIb - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 12:22:00 GMTTourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock TitanStock Titan · Wed, 05 Aug 2026 12:22:00 GMTROJAN FRAGRANCE TRADING (PTY) LTD Launches Phase Two of South Africa Expansion Strategy - The National Law ReviewThe National Law Review · Tue, 04 Aug 2026 07:35:06 GMTAdia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study - TMX NewsfileTMX Newsfile · Wed, 29 Jul 2026 10:00:00 GMT